Novartis highlights scientific advances with Kisqali, iptacopan, Scemblix and YTB323 data at SABCS and ASH

First data to be presented as a late-breaker abstract from global pivotal APPLY-PNH trial of investigational oral monotherapy iptacopan in paroxys...

Related Keywords

United States ,East Hanover ,Pennsylvania ,Philadelphia ,American ,America Julie Masow ,Jeff Legos ,Michael Meo ,Mary Carmichael ,Prnewswire Novartis ,America Sloan Simpson ,Novartis Institutes For Biomedical Research ,Twitter ,Marrow Transplant Research ,Astex Pharmaceuticals ,International Blood ,Novartis ,Exchange Commission ,Global Head Of Oncology Hematology Development ,American Society Of Hematology ,Nj Novartis Pharmaceuticals Corporation ,International Prognostic Scoring Systems ,Antonio Breast Cancer Symposium ,American Society ,Annual Meeting ,Executive Vice President ,Global Head ,Hematology Development ,Presentation Details ,Oral Presentation ,Presentation Tuesday ,Presentation Sunday ,Pharmaceuticals Corporation ,Novartis Institutes ,Biomedical Research ,Media Relationse Mail ,Investor Relationse Mail ,